Literature DB >> 22785560

Releasing the break on X chromosome inactivation: Rnf12/RLIM targets REX1 for degradation.

Ingolf Bach1.   

Abstract

One of the two X chromosomes in cells of female mammals is transcriptionally silenced in a process known as X chromosome inactivation (XCI). Initiation of XCI is regulated by the ubiquitin ligase Rnf12/RLIM, but the mechanisms by which Rnf12/RLIM mediates this process has been a mystery. A recent study by Gontan et al. shows that Rnf12/RLIM targets REX1, an inhibitor of XCI, for proteasomal degradation, providing an answer to this question.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22785560      PMCID: PMC3494387          DOI: 10.1038/cr.2012.98

Source DB:  PubMed          Journal:  Cell Res        ISSN: 1001-0602            Impact factor:   25.617


  16 in total

1.  RNF12 initiates X-chromosome inactivation by targeting REX1 for degradation.

Authors:  Cristina Gontan; Eskeatnaf Mulugeta Achame; Jeroen Demmers; Tahsin Stefan Barakat; Eveline Rentmeester; Wilfred van IJcken; J Anton Grootegoed; Joost Gribnau
Journal:  Nature       Date:  2012-04-29       Impact factor: 49.962

2.  Ubiquitination-dependent cofactor exchange on LIM homeodomain transcription factors.

Authors:  Heather P Ostendorff; Reto I Peirano; Marvin A Peters; Anne Schlüter; Michael Bossenz; Martin Scheffner; Ingolf Bach
Journal:  Nature       Date:  2002-03-07       Impact factor: 49.962

3.  RLIM inhibits functional activity of LIM homeodomain transcription factors via recruitment of the histone deacetylase complex.

Authors:  I Bach; C Rodriguez-Esteban; C Carrière; A Bhushan; A Krones; D W Rose; C K Glass; B Andersen; J C Izpisúa Belmonte; M G Rosenfeld
Journal:  Nat Genet       Date:  1999-08       Impact factor: 38.330

4.  Expression of REX-1, a gene containing zinc finger motifs, is rapidly reduced by retinoic acid in F9 teratocarcinoma cells.

Authors:  B A Hosler; G J LaRosa; J F Grippo; L J Gudas
Journal:  Mol Cell Biol       Date:  1989-12       Impact factor: 4.272

5.  Maternal Rnf12/RLIM is required for imprinted X-chromosome inactivation in mice.

Authors:  Jongdae Shin; Michael Bossenz; Young Chung; Hong Ma; Meg Byron; Naoko Taniguchi-Ishigaki; Xiaochun Zhu; Baowei Jiao; Lisa L Hall; Michael R Green; Stephen N Jones; Irm Hermans-Borgmeyer; Jeanne B Lawrence; Ingolf Bach
Journal:  Nature       Date:  2010-10-21       Impact factor: 49.962

6.  RNF12 is an X-Encoded dose-dependent activator of X chromosome inactivation.

Authors:  Iris Jonkers; Tahsin Stefan Barakat; Eskeatnaf Mulugeta Achame; Kim Monkhorst; Annegien Kenter; Eveline Rentmeester; Frank Grosveld; J Anton Grootegoed; Joost Gribnau
Journal:  Cell       Date:  2009-11-25       Impact factor: 41.582

7.  Analysis of Rex1 (zfp42) function in embryonic stem cell differentiation.

Authors:  Kymora B Scotland; Siming Chen; Renia Sylvester; Lorraine J Gudas
Journal:  Dev Dyn       Date:  2009-08       Impact factor: 3.780

8.  Regulation of estrogen-dependent transcription by the LIM cofactors CLIM and RLIM in breast cancer.

Authors:  Steven A Johnsen; Cenap Güngör; Tanja Prenzel; Sabine Riethdorf; Lutz Riethdorf; Naoko Taniguchi-Ishigaki; Thomas Rau; Baris Tursun; J David Furlow; Guido Sauter; Martin Scheffner; Klaus Pantel; Frank Gannon; Ingolf Bach
Journal:  Cancer Res       Date:  2009-01-01       Impact factor: 12.701

9.  Proteasomal selection of multiprotein complexes recruited by LIM homeodomain transcription factors.

Authors:  Cenap Güngör; Naoko Taniguchi-Ishigaki; Hong Ma; Alexander Drung; Baris Tursun; Heather P Ostendorff; Michael Bossenz; Catherina G Becker; Thomas Becker; Ingolf Bach
Journal:  Proc Natl Acad Sci U S A       Date:  2007-09-11       Impact factor: 11.205

10.  Rex1/Zfp42 is dispensable for pluripotency in mouse ES cells.

Authors:  Shinji Masui; Satoshi Ohtsuka; Rika Yagi; Kadue Takahashi; Minoru S H Ko; Hitoshi Niwa
Journal:  BMC Dev Biol       Date:  2008-04-24       Impact factor: 1.978

View more
  1 in total

1.  An RNF12-USP26 amplification loop drives germ cell specification and is disrupted by disease-associated mutations.

Authors:  Anna Segarra-Fas; Carmen Espejo-Serrano; Francisco Bustos; Houjiang Zhou; Feng Wang; Rachel Toth; Thomas Macartney; Ingolf Bach; Gino Nardocci; Greg M Findlay
Journal:  Sci Signal       Date:  2022-07-12       Impact factor: 9.517

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.